AU2018901953A0 - Systems, devices and methods for the treatment of oral and pharyngeal disorders - Google Patents

Systems, devices and methods for the treatment of oral and pharyngeal disorders

Info

Publication number
AU2018901953A0
AU2018901953A0 AU2018901953A AU2018901953A AU2018901953A0 AU 2018901953 A0 AU2018901953 A0 AU 2018901953A0 AU 2018901953 A AU2018901953 A AU 2018901953A AU 2018901953 A AU2018901953 A AU 2018901953A AU 2018901953 A0 AU2018901953 A0 AU 2018901953A0
Authority
AU
Australia
Prior art keywords
oral
systems
treatment
methods
devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018901953A
Inventor
Lynne Bilston
Peter Burke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEUROSCIENCE RESEARCH AUSTRALIA (NEURA)
Original Assignee
NEUROSCIENCE RESEARCH AUSTRALIA (NEURA)
Filing date
Publication date
Application filed by NEUROSCIENCE RESEARCH AUSTRALIA (NEURA) filed Critical NEUROSCIENCE RESEARCH AUSTRALIA (NEURA)
Publication of AU2018901953A0 publication Critical patent/AU2018901953A0/en
Priority to EP19810215.4A priority Critical patent/EP3801758A4/en
Priority to CA3102040A priority patent/CA3102040A1/en
Priority to PCT/AU2019/050532 priority patent/WO2019227150A1/en
Priority to CN201980049855.4A priority patent/CN112469472B/en
Priority to JP2021517083A priority patent/JP2021535812A/en
Priority to US17/059,649 priority patent/US20210260398A1/en
Priority to AU2019277199A priority patent/AU2019277199B2/en
Priority to JP2023166846A priority patent/JP2023169401A/en
Abandoned legal-status Critical Current

Links

AU2018901953A 2018-05-31 2018-05-31 Systems, devices and methods for the treatment of oral and pharyngeal disorders Abandoned AU2018901953A0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP19810215.4A EP3801758A4 (en) 2018-05-31 2019-05-29 Systems, devices and methods for the treatment of oral and pharyngeal disorders
CA3102040A CA3102040A1 (en) 2018-05-31 2019-05-29 Systems, devices and methods for the treatment of oral and pharyngeal disorders
PCT/AU2019/050532 WO2019227150A1 (en) 2018-05-31 2019-05-29 Systems, devices and methods for the treatment of oral and pharyngeal disorders
CN201980049855.4A CN112469472B (en) 2018-05-31 2019-05-29 Systems, devices and methods for treating oral and pharyngeal diseases
JP2021517083A JP2021535812A (en) 2018-05-31 2019-05-29 Systems, devices and methods for the treatment of oropharyngeal disorders
US17/059,649 US20210260398A1 (en) 2018-05-31 2019-05-29 Systems, devices and methods for the treatment of oral and pharyngeal disorders
AU2019277199A AU2019277199B2 (en) 2018-05-31 2019-05-29 Systems, devices and methods for the treatment of oral and pharyngeal disorders
JP2023166846A JP2023169401A (en) 2018-05-31 2023-09-28 Systems, devices and methods for treatment of oral and pharyngeal disorders

Publications (1)

Publication Number Publication Date
AU2018901953A0 true AU2018901953A0 (en) 2018-06-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP3801758A4 (en) Systems, devices and methods for the treatment of oral and pharyngeal disorders
EP3570844A4 (en) Azolopyrimidine for the treatment of cancer-related disorders
EP3746135A4 (en) Methods and compounds for treating disorders
EP3618829A4 (en) Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
IL276883A (en) Compositions, devices, systems, kits and methods for the treatment of a skin condition
EP3634417A4 (en) Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders
EP3672500A4 (en) Devices, systems, and methods for the treatment of vascular defects
EP3484577A4 (en) Methods and systems for treating pelvic disorders and pain conditions
EP3515395A4 (en) Methods and systems for adaptive treatment of disorders in the gastrointestinal tract
EP3684418A4 (en) Methods for the treatment of cysteamine sensitive disorders
EP3749407A4 (en) Devices, methods, and systems for the treatment and/or monitoring of damaged tissue
EP3801744A4 (en) Method and device for treating sleep related breathing disorders
EP3538189A4 (en) Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
EP3955839A4 (en) Devices, systems and methods for the treatment of abnormal tissue
EP3583113A4 (en) Use of tgf alpha for the treatment of diseases and disorders
EP3810049A4 (en) Systems and methods for treating neurological disorders
EP3866736A4 (en) Methods and devices for treating sleep apnea
EP3570773A4 (en) Ultrasonic methods and devices for orthodontic treatment with aligners
EP3729230A4 (en) Methods for managing behavioral treatment therapy and devices thereof
EP3614981A4 (en) Systems, methods and devices for controlling the progression of myopia
EP3566055A4 (en) Methods for the treatment of neurological disorders
EP3813704B8 (en) Systems for treatment of nasal disorders
EP3697387A4 (en) Combination of as1411 and sapc-dops for the treatment of glioblastoma multiforme
EP3661502A4 (en) Compounds for the prevention and treatment of medical disorders and uses thereof
EP4010075A4 (en) Methods for the treatment of apoc3-related diseases and disorders